Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 30, Number 9—September 2024
Research
Medical Costs of Nontuberculous Mycobacterial Pulmonary Disease, South Korea, 2015–2019
Table 1
Definitions of visits related to NTM-PD and assessment costs based on category and relevance of treatment used in study of medical costs of NTM-PD, South Korea, 2015–2019*
| Variable |
Examples |
|---|---|
| Category | |
| Medications | All medications, all fees for drug administration (i.e., intravenous access) and dispensing |
| Diagnostic tests | Acid fast bacilli smear/cultures, NTM identification, NTM drug-susceptibility tests, laboratory tests using patient specimen (i.e., complete blood count, blood chemistry, urinalysis), imaging studies (e.g., computed tomography, radiography), pulmonary function tests, induced sputum, invasive procedures (e.g., bronchoscopy, radiologic intervention) |
| Clinical services | Doctors’ fees for admission, outpatient visits, and consultation; hospital fees; meals during admission; fees for documentation |
*NTM-PD-related visits were defined as all visits to the pulmonology department and nonpulmonology visits, including outpatient referrals for management of adverse events during NTM-PD treatment, consultations during admissions for NTM-PD management, and visits for surgical management of NTM-PD. Non-NTM-PD–related visits defined as all nonpulmonology visits that do not fit the criteria for an NTM-PD-related visit (i.e., visits for hypertension). NTM, nontuberculous mycobacteria; PD, pulmonary disease.
1These first authors contributed equally to this article.
2These authors were co–principal investigators.